REGENXBIO Inc. (RGNX) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome, everyone, to the first quarter 2025 Regenexx Bio Earnings Conference call. At this time, all participants are in listen-only mode. After the speaker's prepared remarks, we will conduct a question and answer session. To ask a question, please press star 1-1. To remove yourself from the queue, please press star 1-1 again. As a reminder, this call may be recorded. At this time, I'd like to turn the conference over to Patrick Christmas, Chief Legal Officer of Regenexx Bio. Please go ahead. Good afternoon, and thank you for joining us today. Earlier this afternoon, Regenexx Bio released financial and operating results for the first quarter ended March 31st, 2025. The press release is available on our website at www.regenexxbio.com. Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted and can be identified by words such as expect, plan, will, may, anticipate, believe, should, intend, and other words of similar meaning. Any such forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties. These risks are described in the risk factors in the management discussion and analysis section of Regenexx BIO's annual report on Form 10-K for the full year ended December 31st, 2020, and comparable factors and sections of Regenexx BIO's quarterly reports on Form 10-Q, which are on file with the Securities and Exchange Commission and available on the SEC's website. Any information we provide on this conference call is provided only as of the date of this call, May 12th, 2025, and we undertake no ob...